ULTIMA-PT-141 10mg – Ultima Pharma USA

ULTIMA-PT-141 10mg by Ultima Pharma USA is a peptide research product containing 10mg of PT-141 (Bremelanotide), supplied as a lyophilized (freeze-dried) peptide in a laboratory-grade vial. Manufactured under the Ultima Pharma USA brand, it is intended for laboratory and research applications. PT-141 is a synthetic melanocortin receptor agonist that has been investigated in scientific research for its receptor interactions, pharmacological properties, and biological activity.

Product Highlights

• Brand: Ultima Pharma USA
• Product Name: ULTIMA-PT-141
• Active Compound: PT-141 (Bremelanotide)
• Strength: 10mg
• Dosage Form: Lyophilized Peptide
• Product Type: Research Peptide
• Peptide Class: Melanocortin Receptor Agonist
• Manufactured under quality-controlled production standards

Product Information

PT-141, also known as Bremelanotide, is a synthetic peptide derived from melanocortin analogues. It has been studied in laboratory and clinical research for its interaction with melanocortin receptors, with investigations focusing on receptor signaling, neurobiology, peptide stability, and pharmacological characteristics.

Ultima Pharma USA supplies ULTIMA-PT-141 10mg as a freeze-dried peptide preparation intended for research use. The formulation, excipients, vial presentation, packaging, and batch specifications may vary depending on the manufacturer’s production process. Customers should always verify product information using the product label and official manufacturer documentation.

Scientific investigations involving PT-141 have focused on receptor pharmacology, peptide chemistry, pharmacokinetics, and biological mechanisms in controlled laboratory settings. These findings do not establish safety or effectiveness for uses outside approved indications.

Product Specifications

Storage Instructions

• Store according to the manufacturer’s recommendations.
• Refrigerate or freeze if specified on the product label.
• Protect from excessive heat, moisture, and direct sunlight.
• Keep the vial sealed until use.
• Store out of the reach of children.

Important Information

ULTIMA-PT-141 is supplied for research purposes, and its regulatory status varies by jurisdiction. It is not approved as an over-the-counter medicine in this formulation. Always comply with applicable laws and verify product authenticity through the manufacturer or an authorized distributor.